Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

301 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Do baseline atrial electrocardiographic and infarction patterns predict new-onset atrial fibrillation after ST-elevation myocardial infarction? Insights from the Assessment of Pexelizumab in Acute Myocardial Infarction Trial.
van Diepen S, Siha H, Fu Y, Westerhout CM, Lopes RD, Granger CB, Armstrong PW; APEX AMI Investigators. van Diepen S, et al. J Electrocardiol. 2010 Jul-Aug;43(4):351-8. doi: 10.1016/j.jelectrocard.2010.04.001. Epub 2010 May 4. J Electrocardiol. 2010. PMID: 20444469 Clinical Trial.
Baseline NT-proBNP and biomarkers of inflammation and necrosis in patients with ST-segment elevation myocardial infarction: insights from the APEX-AMI trial.
van Diepen S, Roe MT, Lopes RD, Stebbins A, James S, Newby LK, Moliterno DJ, Neumann FJ, Ezekowitz JA, Mahaffey KW, Hochman JS, Hamm CW, Armstrong PW, Theroux P, Granger CB. van Diepen S, et al. J Thromb Thrombolysis. 2012 Jul;34(1):106-13. doi: 10.1007/s11239-012-0691-0. J Thromb Thrombolysis. 2012. PMID: 22307842 Clinical Trial.
Transfer times and outcomes in patients with ST-segment-elevation myocardial infarction undergoing interhospital transfer for primary percutaneous coronary intervention: APEX-AMI insights.
van Diepen S, Widimsky P, Lopes RD, White KR, Weaver WD, Van de Werf F, Ardissino D, van't Hof AW, Armstrong PW, Granger CB. van Diepen S, et al. Among authors: van t hof aw, van de werf f. Circ Cardiovasc Qual Outcomes. 2012 Jul 1;5(4):437-44. doi: 10.1161/CIRCOUTCOMES.112.965160. Epub 2012 May 15. Circ Cardiovasc Qual Outcomes. 2012. PMID: 22589297 Free PMC article. Clinical Trial.
Prognostic relevance of baseline pro- and anti-inflammatory markers in STEMI: an APEX AMI substudy.
van Diepen S, Newby LK, Lopes RD, Stebbins A, Hasselblad V, James S, Roe MT, Ezekowitz JA, Moliterno DJ, Neumann FJ, Reist C, Mahaffey KW, Hochman JS, Hamm CW, Armstrong PW, Granger CB, Theroux P; APEX AMI Investigators. van Diepen S, et al. Int J Cardiol. 2013 Oct 3;168(3):2127-33. doi: 10.1016/j.ijcard.2013.01.004. Epub 2013 Feb 8. Int J Cardiol. 2013. PMID: 23394896 Clinical Trial.
Critical care cardiology research: a call to action.
van Diepen S, Cook DJ, Jacka M, Granger CB. van Diepen S, et al. Circ Cardiovasc Qual Outcomes. 2013 Mar 1;6(2):237-42. doi: 10.1161/CIRCOUTCOMES.111.969501. Epub 2013 Mar 5. Circ Cardiovasc Qual Outcomes. 2013. PMID: 23463810 No abstract available.
Left ventricular systolic dysfunction, heart failure, and the risk of stroke and systemic embolism in patients with atrial fibrillation: insights from the ARISTOTLE trial.
McMurray JJ, Ezekowitz JA, Lewis BS, Gersh BJ, van Diepen S, Amerena J, Bartunek J, Commerford P, Oh BH, Harjola VP, Al-Khatib SM, Hanna M, Alexander JH, Lopes RD, Wojdyla DM, Wallentin L, Granger CB; ARISTOTLE Committees and Investigators. McMurray JJ, et al. Among authors: van diepen s. Circ Heart Fail. 2013 May;6(3):451-60. doi: 10.1161/CIRCHEARTFAILURE.112.000143. Epub 2013 Apr 10. Circ Heart Fail. 2013. PMID: 23575255
301 results